跳至主要内容
临床试验/CTRI/2021/09/036468
CTRI/2021/09/036468已完成未知

ââ?¬Å?Dissecting The Virological And Immunological Factors To Predict Outcome In e Negative Chronic Viral Hepatitis B Patients After Cessation Of Nucleoside/Nucleotide Analogueââ?¬?

ational Health Mission0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1 Adult Patients( Age 18-65 Years) with e Antigen Negative Chronic Hepatitis B
  • 2 Continuous Tenofovir or Entecavir Monotherapy for at least 2 Years
  • 3 HBV DNA <250 Copies/ml at The Time of Enrollment
  • 4 Sustained Viral Suppression ( at Least 3 Report of HBV DNA at 6 Months Interval Showing Undetectable Viral Load)

排除标准

  • 1 Patients with significant fibrosis ( Fibroscan >8 Kpa LSM or Liver Biopsy or USG Abdomen shows Cirrhosis, APRI >1.5, FIB4 >3.25
  • 2 Immunocompromised
  • 4 Pregnancy
  • 5 Co-Infection
  • 6 Patient Who Received Dual Antivirals or PEG INF
  • 7 Patients on Lamivudine or Adefovir
  • 8 Patient not Willing to Participate in the Study

研究者

发起方
ational Health Mission

相似试验